Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new Revision label, v3.5.5, replaces the previous v3.5.4, indicating a new build of the page; this update reflects an internal version change rather than alterations to trial information.
    Difference
    0.1%
    Check dated 2026-06-05T10:42:00.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision label (Revision: v3.5.4) was added to the record history, and the previous label (Revision: v3.5.3) was removed.
    Difference
    0.1%
    Check dated 2026-05-15T05:17:06.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision history shows a new page version, from v3.5.2 to v3.5.3, indicating a minor update to the record's metadata.
    Difference
    0.1%
    Check dated 2026-04-30T16:46:33.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the study record history.
    Difference
    0.1%
    Check dated 2026-04-16T10:36:16.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the record history, replacing the previous v3.4.3 entry. This is a metadata update to the history and does not alter the study content or data displayed on the page.
    Difference
    0.1%
    Check dated 2026-03-18T18:07:20.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.3, was added to the history. The prior entry, v3.4.2, was removed from the current view.
    Difference
    0.1%
    Check dated 2026-03-11T17:09:03.000Z thumbnail image

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.